silylenol ether.15 Therefore the protected hydroxylactames
were reduced with superhydride and directly converted to
the acetates (mixture of epimers) with Ac2O. Treatment of
the latter with ethyl-3-phenyl-3-trimethylsiloxy-acrylate (21,
see Supporting Information) under Sc(OTf)3 catalysis pro-
ceeded smoothly and afforded 11 (Scheme 2). Cleavage of
Scheme 3. Synthesis of the Methylketones 4 and 5
Scheme 2. Synthesis of the Lactones 2 and 3
In conclusion, any enantiomer of any diastereomer of the
trisubstituted piperidine-alkaloid substructures of cyclop-
amine and all other jervine- and veratramine-steroid alka-
loids can be obtained from readily available enantiopure
citronellic acids by the two general routes described above,
choosing either (+)-DCCSO or (-)-DCCSO in the hydroxy-
lation step. Hence complete control of stereochemistry of
the three substituents was demonstrated. Furthermore, all
transformations proceeded in high yield and were shown to
be scalable up to multigram quantities. We are therefore
confident that implementation of this route will open access
to new analogues and total syntheses of this interesting class
of natural products.
the benzoyl moiety was affected by a retro-Claisen reaction
using LiOH, and deprotection of the hydroxy group and the
carboxylic acid gave the seco-acid which was immediately
cyclized with EDC (1-(3-dimethylaminopropyl)-3-ethylcar-
bodiimide) to give the five-membered lactones 2 and 3,
respectively (63-59% yield over five steps). From both 2
and 3, several grams were prepared using this sequence.
A syn-addition to C-2 was achieved by the following
sequence: Methylenation using the Petasis conditions16 and
subsequent hydroboration/oxidation gave the regioisomeric
alcohols 13 and 14 with complete stereocontrol. The occur-
rence of 14 in this reaction must be attributed to a pivaloyl
shift. Both compounds 13 and 14 were converted to the
benzyl-protected diol 15 using standard protecting group
manipulations.
Acknowledgment. We thank Dr. Lothar Hennig (Univer-
sita¨t Leipzig) for recording NMR spectra and for his help in
interpreting the 2D-NMR spectra. The Deutsche Forschungs-
gemeinschaft (DFG) is acknowledged for partial financial
support. Dr. Philipp Heretsch is a fellow of Fonds der
Chemischen Industrie.
Further elaboration into 4 was carried out by oxidation
using the Dess-Martin-periodinane (DMP), Grignard reac-
tion with methylmagnesium bromide, and again oxidation
of the epimeric alcohols with DMP to yield the methylketone
4 as the only product. These transformations proceeded in a
total yield of 15% over seven or nine steps, respectively.
Starting from (-)-9 the all-cis substituted methylketone 5
could be accessed in the same way but with only minute
amounts of pivaloyl-shifted material to be produced during
the hydroboration/oxidation reaction, in a total yield of 23%
over nine steps (Scheme 3).
Supporting Information Available: Experimental pro-
1
cedures, compound characterization, and H NMR and 13C
NMR data for all compounds. 2D-NMR spectral data for
selected compounds. This material is available free of charge
OL902270F
(11) This access is both shorter and more efficient than a seminal work
by Woodward et al. dealing with the assignment of the absolute stereo-
chemistry of the Veratrum alkaloids: Jeger, O.; Prelog, V.; Sundt, E.;
Woodward, R. B. HelV. Chim. Acta 1954, 37, 2302–2306.
(12) Yu, W.; Mei, Y.; Kang, Y.; Hua, Z.; Jin, Z. Org. Lett. 2004, 6,
3217–3219.
(6) (a) Jiang, Y.; Li, H.; Li, P.; Cai, Z.; Ye, W. J. Nat. Prod. 2005, 68,
264–267. (b) Jiang, Y.; Li, P.; Li, H.-J.; Yu, H. Steroids 2006, 71, 843–
848. (c) Li, H.-J.; Jiang, Y.; Li, P.; Ye, W.-C. Chem. Pharm. Bull. 2006,
54, 722–724.
(13) Chen, B.-C.; Murphy, C. K.; Kumar, A.; Thimma Reddy, R.; Clark,
C.; Zhou, P.; Lewis, B. M.; Gala, D.; Mergelsberg, I.; Scherer, D.; Buckley,
J.; DiBenedetto, D.; Davis, F. A. Org. Synth. 1996, 73, 159–167.
(14) A chemoenzymatic approach described by Willis et al. is both more
tedious and of lower total yield and gives in addition only access to products
with stereochemistry resembling that of (-)-9 and (-)-10: Crosby, S.;
Hateley, M. J.; Willis, C. L. Tetrahedron Lett. 2000, 41, 397–401.
(15) Okitsu, O.; Suzuki, R.; Kobayashi, S. J. Org. Chem. 2001, 66, 809–
823.
(7) Qian, Z.-Z.; Nohara, T. Phytochemistry 1995, 40, 979–981.
(8) Zhang, J. X.; Lao, A. N.; Xu, R. S. Chin. J. Org. Chem. 1994, 14,
289–292.
(9) Hashimoto, S.-I.; Yamada, S.-I.; Koga, K. Chem. Pharm. Bull. 1979,
27, 771–782.
(10) Overberger, C. G.; Weise, J. K. J. Am. Chem. Soc. 1968, 90, 3525–
3532.
(16) Petasis, N. A.; Bzowej, E. I. J. Am. Chem. Soc. 1990, 112, 6392–
6394.
5412
Org. Lett., Vol. 11, No. 23, 2009